A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies

التفاصيل البيبلوغرافية
العنوان: A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies
المؤلفون: Dimitrios Daoussis, Thomas Scheper, George Efthymiou, Theodora Simopoulou, Christina G. Katsiari, Wolfgang Meyer, Christos Liaskos, Athanasios Gkoutzourelas, Alexandra Tsirogianni, Efthymios Dardiotis, Christina Tsigalou, Dimitrios P. Bogdanos, Lazaros I. Sakkas
المصدر: Rheumatology international. 40(10)
سنة النشر: 2020
مصطلحات موضوعية: Human cytomegalovirus, Male, medicine.medical_specialty, Anti-Cytomegalovirus Antibody, Immunology, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Antigen, Antigen specific, Internal medicine, medicine, Immunology and Allergy, Humans, Lupus Erythematosus, Systemic, 030212 general & internal medicine, skin and connective tissue diseases, Autoantibodies, 030203 arthritis & rheumatology, Scleroderma, Systemic, biology, business.industry, Autoantibody, medicine.disease, Sjogren's Syndrome, Ribonucleoproteins, Concomitant, Case-Control Studies, biology.protein, Female, Antibody, business, Biomarkers
الوصف: Anti-Ro52 autoantibody (autoAb), highly prevalent in Sjogren’s syndrome (SjS) and systemic lupus erythematosus (SLE), is also frequent in systemic sclerosis (SSc). Viral agents, such as human cytomegalovirus (HCMV), have been considered as a trigger for SSc and SSc-associated autoAbs. To seek for antigen-specific anti-HCMV associations with anti-Ro52, we assessed the dominant anti-HCMV ab responses in anti-Ro52 antibody (ab)-positive and -negative patients with SSc and compared them with those in SLE and SjS. 116 Anti-HCMV ab(+) sera were analyzed, including 70 from anti-Ro52(+) patients (29 SSc, 23 SLE and 18 SjS) and 46 from anti-Ro52(−) patients (29 with SSc, 9 with SLE and 8 with SjS) as negative controls. Abs against specific HCMV pp130/UL57, pp65/UL83, pp55/UL55, pp52/UL44, p38 and pp28/UL99 antigens were tested by immunoblotting. Anti-Ro52(+) SSc patients reacted more frequently against pp52/UL44 and p38 compared to anti-Ro52(−) [(13/29, 44.8%; 95% CI 26.7–62.9% vs. 1/29, 3.4%; 95% CI 0–10%, p
تدمد: 1437-160X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2914fc134dd4d78ef9df791765997f5Test
https://pubmed.ncbi.nlm.nih.gov/32681396Test
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....e2914fc134dd4d78ef9df791765997f5
قاعدة البيانات: OpenAIRE